New study aims to crack sepsis diagnosis with advanced genetics

NCT ID NCT07599644

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is collecting blood and urine samples from 1,400 ICU patients in China to find new biological markers for sepsis. Researchers will analyze genes, proteins, and metabolites to build faster and more accurate diagnostic tests. The goal is to help doctors identify sepsis earlier and predict which patients are at higher risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to faster and more accurate sepsis diagnosis and risk assessment tools for ICU patients.

What could go wrong

This is an observational study, not a treatment trial. The findings may not translate into clinical practice or benefit patients directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

disease infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Yuebei People's Hospital

    RECRUITING

    Shaoguan, Guangdong, 512026, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••